HomeCompareKMED vs NNN

KMED vs NNN: Dividend Comparison 2026

KMED yields 10.63% · NNN yields 5.66%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KMED wins by $14.9K in total portfolio value
10 years
KMED
KMED
● Live price
10.63%
Share price
$18.81
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.4K
Annual income
$2,071.13
Full KMED calculator →
NNN
NNN REIT Inc.
● Live price
5.66%
Share price
$42.03
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.5K
Annual income
$2,622.67
Full NNN calculator →

Portfolio growth — KMED vs NNN

📍 KMED pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKMEDNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KMED + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KMED pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KMED
Annual income on $10K today (after 15% tax)
$903.81/yr
After 10yr DRIP, annual income (after tax)
$1,760.46/yr
NNN
Annual income on $10K today (after 15% tax)
$481.32/yr
After 10yr DRIP, annual income (after tax)
$2,229.27/yr
At 15% tax rate, NNN beats the other by $468.81/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KMED + NNN for your $10,000?

KMED: 50%NNN: 50%
100% NNN50/50100% KMED
Portfolio after 10yr
$32.9K
Annual income
$2,346.90/yr
Blended yield
7.12%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

KMED
No analyst data
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+6.9% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KMED buys
0
NNN buys
0
No recent congressional trades found for KMED or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKMEDNNN
Forward yield10.63%5.66%
Annual dividend / share$2.00$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6%
Portfolio after 10y$40.4K$25.5K
Annual income after 10y$2,071.13$2,622.67
Total dividends collected$15.6K$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: KMED vs NNN ($10,000, DRIP)

YearKMED PortfolioKMED Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$11,763$1,063.31$10,735$614.96+$1.0KKMED
2$13,756$1,168.98$11,572$708.43+$2.2KKMED
3$15,996$1,277.54$12,531$819.53+$3.5KKMED
4$18,504$1,388.43$13,633$952.29+$4.9KKMED
5$21,301$1,501.06$14,909$1,111.84+$6.4KKMED
6$24,407$1,614.86$16,392$1,304.77+$8.0KKMED
7$27,844$1,729.28$18,129$1,539.52+$9.7KKMED
8$31,637$1,843.78$20,173$1,827.08+$11.5KKMED
9$35,810$1,957.89$22,597$2,181.81+$13.2KKMED
10$40,388$2,071.13$25,491$2,622.67+$14.9KKMED

KMED vs NNN: Complete Analysis 2026

KMEDStock

The fund will invest at least 80% of its net assets in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index includes companies that RBICS classifies as engaged in the pharmaceuticals, biotechnology, medical specialties, managed health care, hospital/nursing management, medical/nursing services and services to the health industry businesses. The fund is non-diversified.

Full KMED Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this KMED vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KMED vs SCHDKMED vs JEPIKMED vs OKMED vs KOKMED vs MAINKMED vs ADCKMED vs EPRTKMED vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.